Literature DB >> 23226799

Recurrent prognostic factors and expression of GLUT-1, PI3K and p-Akt in adenoid cystic carcinomas of the head and neck: Clinicopathological features and biomarkers of adenoid cystic carcinoma.

Jin Fang1, Yang-Yang Bao, Shui-Hong Zhou, Xing-Mei Luo, Hong-Tian Yao, Jian-Feng He, Qin-Ying Wang.   

Abstract

The purpose of this study was to explore the factors associated with the recurrence of adenoid cystic carcinomas (ACCs). We examined the recurrence values of clinicopathological variables and GLUT-1, p-Akt and PI3K expression in 42 patients with ACC. Of the 42 patients, 17 developed recurrence following initial surgery. The positive rates of GLUT-1, PI3K and p-Akt protein expression in ACC were 38.1, 38.1 and 50.0%, respectively. The expression of GLUT-1, p-Akt or PI3K protein in ACC was higher than that in inflammatory lesions or benign tumors. Our study demonstrated that T stage, a positive resection margin, perineural invasion, surgery without postoperative radiotherapy and the expression of GLUT-1, PI3K and p-Akt were factors predictive of recurrence by univariate analyses. In multivariate analyses, perineural invasion, a positive resection margin and p-Akt were significant predictors of recurrence. Initial surgery is very significant in the recurrence of ACC. Overexpression of GLUT-1, PI3K and p-Akt may also play a role in its development and recurrence.

Entities:  

Year:  2012        PMID: 23226799      PMCID: PMC3506780          DOI: 10.3892/ol.2012.895

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  34 in total

1.  Role of radiotherapy in adenoid cystic carcinoma of the head and neck.

Authors:  T A Iseli; L H Karnell; S M Graham; G F Funk; J M Buatti; A K Gupta; R A Robinson; H T Hoffman
Journal:  J Laryngol Otol       Date:  2009-07-02       Impact factor: 1.469

2.  Clinicopathologic and molecular significance of phospho-Akt expression in early invasive breast cancer.

Authors:  Mohammed A Aleskandarany; Emad A Rakha; Mohamed A Ahmed; Desmond G Powe; Ian O Ellis; Andrew R Green
Journal:  Breast Cancer Res Treat       Date:  2010-07-09       Impact factor: 4.872

3.  Risk factors for local recurrence of adenoid cystic carcinoma: the role of postoperative radiation therapy.

Authors:  E P Prokopakis; C H Snyderman; E Y Hanna; R L Carrau; J T Johnson; F D'Amico
Journal:  Am J Otolaryngol       Date:  1999 Sep-Oct       Impact factor: 1.808

4.  Akt-directed glucose metabolism can prevent Bax conformation change and promote growth factor-independent survival.

Authors:  Jeffrey C Rathmell; Casey J Fox; David R Plas; Peter S Hammerman; Ryan M Cinalli; Craig B Thompson
Journal:  Mol Cell Biol       Date:  2003-10       Impact factor: 4.272

5.  Apigenin inhibits the GLUT-1 glucose transporter and the phosphoinositide 3-kinase/Akt pathway in human pancreatic cancer cells.

Authors:  Laleh G Melstrom; Mohammad R Salabat; Xian-Zhong Ding; Benjamin M Milam; Matthew Strouch; Jill C Pelling; David J Bentrem
Journal:  Pancreas       Date:  2008-11       Impact factor: 3.327

6.  Expression of glucose transporter-1 and -3 in the head and neck carcinoma--the correlation of the expression with the biological behaviors.

Authors:  Shuihong Zhou; Shenqing Wang; Qiuliang Wu; Jun Fan; Qinying Wang
Journal:  ORL J Otorhinolaryngol Relat Spec       Date:  2008-04-09       Impact factor: 1.538

7.  Clinical significance of FDG single-photon emission computed tomography: Computed tomography in the diagnosis of head and neck cancers and study of its mechanism.

Authors:  Ling-Fa Li; Shui-Hong Zhou; Kui Zhao; Shen-Qing Wang; Qiu-Liang Wu; Jun Fan; Ke-Jia Cheng; Ling Ling
Journal:  Cancer Biother Radiopharm       Date:  2008-12       Impact factor: 3.099

8.  Comparison of [18F]fluorodeoxyglucose uptake with glucose transporter-1 expression and proliferation rate in human glioma and non-small-cell lung cancer.

Authors:  J K Chung; Y J Lee; S K Kim; J M Jeong; D S Lee; M C Lee
Journal:  Nucl Med Commun       Date:  2004-01       Impact factor: 1.690

9.  Adenoid cystic carcinoma of the lung: interest of 18FDG PET/CT in the management of an atypical presentation.

Authors:  Marion Campistron; Isabelle Rouquette; Fréderick Courbon; Valérie Chabbert; Philippe Rochaix; Grégoire Prévot; Sophie Laroumagne; Laurent Têtu; Alain Didier; Julien Mazières
Journal:  Lung Cancer       Date:  2007-07-20       Impact factor: 5.705

10.  Expression of p-AKT characterizes adenoid cystic carcinomas of head and neck with a higher risk for tumor relapses.

Authors:  Hans-Ullrich Völker; Matthias Scheich; Annette Berndt; Imme Haubitz; Alexandra Metzger; Hans-Konrad Müller-Hermelink; Ulrike Kämmerer; Melanie Schmidt
Journal:  Diagn Pathol       Date:  2009-06-19       Impact factor: 2.644

View more
  5 in total

1.  Transcription factor ATF3 mediates the radioresistance of breast cancer.

Authors:  Wenyan Zhao; Ming Sun; Shuqiang Li; Zhaofu Chen; Donghua Geng
Journal:  J Cell Mol Med       Date:  2018-08-17       Impact factor: 5.310

2.  Fluorodeoxyglucose uptake in laryngeal carcinoma is associated with the expression of glucose transporter-1 and hypoxia-inducible-factor-1α and the phosphoinositide 3-kinase/protein kinase B pathway.

Authors:  Kui Zhao; Shu-Ye Yang; Shui-Hong Zhou; Meng Jie Dong; Yang-Yang Bao; Hong-Tian Yao
Journal:  Oncol Lett       Date:  2014-02-12       Impact factor: 2.967

3.  Expression of hypoxia-related markers in inflammatory myofibroblastic tumors of the head and neck.

Authors:  Kui-Rong Wang; Tao Jiang; Ting-Ting Wu; Shui-Hong Zhou; Hong-Tian Yao; Qin-Ying Wang; Zhong-Jie Lu
Journal:  World J Surg Oncol       Date:  2013-11-19       Impact factor: 2.754

4.  Apigenin inhibits the proliferation of adenoid cystic carcinoma via suppression of glucose transporter-1.

Authors:  Jin Fang; Yang-Yang Bao; Shui-Hong Zhou; Jun Fan
Journal:  Mol Med Rep       Date:  2015-08-20       Impact factor: 2.952

5.  Overexpression of Malic Enzyme 2 Indicates Pathological and Clinical Significance in Oral Squamous Cell Carcinoma.

Authors:  Jun-Jie Zhou; Yao Xiao; Hao Li; Cong-Cong Wu; De-Run Chen; Lei Chen; Wei-Wei Deng; Wen-Feng Zhang; Zhi-Jun Sun
Journal:  Int J Med Sci       Date:  2020-03-05       Impact factor: 3.738

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.